|
|
|
1-10 employees
View all Neurogastrx, Inc. employees
|
|
Pharmaceuticals
|
|
600 Unicorn Park Dr, Woburn, Massachusetts 01801, US
|
|
We are a privately held, late clinical-stage biopharmaceutical company that is focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) diseases. We believe that the lack of innovation and limited treatment options for GI patients present us with a significant opportunity to address this large unmet medical need. Initially, we are focused on pursuing indications for the treatment of patients suffering from erosive esophagitis (EE) and gastroparesis. We believe our approach, which is targeted to the gastroenterology community, combined with the experience of our management team in developing and commercializing medicines in the GI space, positions us to identify, develop and efficiently bring to market solutions for GI diseases with limited innovation and/or treatment options.
|
James O'mara is the CEO of Neurogastrx, Inc.. To contact James O'mara email at [email protected].
The decision makers in Neurogastrx, Inc. are Cyril De Colle, James O'mara, Pankaj Jay Pasricha, etc. Click to Find Neurogastrx, Inc. decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.